| Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates Y Simoni, E Becht, M Fehlings, CY Loh, SL Koo, KWW Teng, JPS Yeong, ... Nature 557 (7706), 575-579, 2018 | 1073 | 2018 |
| Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy WCC Tan, SN Nerurkar, HY Cai, HHM Ng, D Wu, YTF Wee, JCT Lim, ... Cancer Communications 40 (4), 135-153, 2020 | 418 | 2020 |
| Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma M Garnelo, A Tan, Z Her, J Yeong, CJ Lim, J Chen, KH Lim, A Weber, ... Gut 66 (2), 342-351, 2017 | 415 | 2017 |
| Genomic landscape of lung adenocarcinoma in East Asians J Chen, H Yang, ASM Teo, LB Amer, FG Sherbaf, CQ Tan, JJS Alvarez, ... Nature genetics 52 (2), 177-186, 2020 | 316 | 2020 |
| Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma CJ Lim, YH Lee, L Pan, L Lai, C Chua, M Wasser, TKH Lim, J Yeong, ... Gut 68 (5), 916-927, 2019 | 267 | 2019 |
| PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity TS Lim, V Chew, JL Sieow, S Goh, JPS Yeong, AL Soon, ... Oncoimmunology 5 (3), e1085146, 2016 | 179 | 2016 |
| Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer H Matsumoto, AA Thike, H Li, J Yeong, S Koo, RA Dent, PH Tan, J Iqbal Breast cancer research and treatment 156, 237-247, 2016 | 159 | 2016 |
| Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19 CCL Cheung, D Goh, X Lim, TZ Tien, JCT Lim, JN Lee, B Tan, ZEA Tay, ... Gut 71 (1), 226-229, 2022 | 131 | 2022 |
| Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer J Yeong, AA Thike, JCT Lim, B Lee, H Li, SC Wong, SSS Hue, PH Tan, ... Breast cancer research and treatment 163, 21-35, 2017 | 126 | 2017 |
| High densities of tumor-associated plasma cells predict improved prognosis in triple negative breast cancer J Yeong, JCT Lim, B Lee, H Li, N Chia, CCH Ong, WK Lye, TC Putti, ... Frontiers in immunology 9, 1209, 2018 | 121 | 2018 |
| Prognostic value of CD8+ PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer J Yeong, JCT Lim, B Lee, H Li, CCH Ong, AA Thike, WH Yeap, Y Yang, ... Journal for immunotherapy of cancer 7, 1-13, 2019 | 94 | 2019 |
| Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma HHM Ng, RY Lee, S Goh, ISY Tay, X Lim, B Lee, V Chew, H Li, B Tan, ... Journal for immunotherapy of cancer 8 (2), 2020 | 85 | 2020 |
| Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma Y Cheng, B Gunasegaran, HD Singh, CA Dutertre, CY Loh, JQ Lim, ... Immunity 54 (8), 1825-1840. e7, 2021 | 74 | 2021 |
| An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use JCT Lim, JPS Yeong, CJ Lim, CCH Ong, SC Wong, VSP Chew, ... Pathology 50 (3), 333-341, 2018 | 74 | 2018 |
| Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma JY Chan, JQ Lim, J Yeong, V Ravi, P Guan, A Boot, TKY Tay, ... The Journal of clinical investigation 130 (11), 5833-5846, 2020 | 70 | 2020 |
| Activation and regulation of interferon-β in immune responses WX Sin, P Li, JPS Yeong, KC Chin Immunologic research 53, 25-40, 2012 | 70 | 2012 |
| Pan-cancer analysis connects tumor matrisome to immune response SB Lim, MLK Chua, JPS Yeong, SJ Tan, WT Lim, CT Lim NPJ precision oncology 3 (1), 15, 2019 | 66 | 2019 |
| Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC J Yeong, T Tan, ZL Chow, Q Cheng, B Lee, A Seet, JX Lim, JCT Lim, ... Journal of Clinical Pathology 73 (9), 557-562, 2020 | 65 | 2020 |
| Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial D Tai, K Loke, A Gogna, NA Kaya, SH Tan, T Hennedige, D Ng, F Irani, ... The Lancet Gastroenterology & Hepatology 6 (12), 1025-1035, 2021 | 61 | 2021 |
| Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma YH Huang, CZ Zhang, QS Huang, J Yeong, F Wang, X Yang, YF He, ... Journal of hepatology 74 (4), 838-849, 2021 | 59 | 2021 |
